Cary Pfeffer serves as Executive at Neon Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Cary Pfeffer has executed 11 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Nov 12, 2021 involved selling 0 shares valued at $0.
Cary Pfeffer currently holds 0 shares of Neon Therapeutics, Inc. (NTGN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Cary Pfeffer has been a net neutral trader of NTGN stock. They have purchased $0 and sold $0 worth of shares.
Cary Pfeffer's most recent insider trade was on Nov 12, 2021, when they sold 0 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jun 10, 2021 | JNCE | $0 | Other | 0 | $N/A | Discretionary |
| Mar 11, 2021 | JNCE | $0 | Other | 0 | $N/A | Discretionary |
| Mar 1, 2021 | JNCE | $0 | Sale | 0 | $N/A | Discretionary |
| Nov 19, 2020 | JNCE | $0 | Sale | 0 | $N/A | Discretionary |
| Nov 17, 2020 | JNCE | $0 | Sale | 0 | $N/A | Discretionary |
| Nov 11, 2020 | JNCE | $0 | Other | 0 | $N/A | Discretionary |
| May 6, 2020 | NTGN | $0 | Disposition | 0 | $N/A | Discretionary |
| Jun 29, 2018 | NTGN | $0 | Conversion | 0 | $N/A | Discretionary |
| Jun 29, 2018 | NTGN | $0 | Conversion | 0 | $N/A | Discretionary |